Gilles Lambert

14.3k total citations · 3 hit papers
138 papers, 10.4k citations indexed

About

Gilles Lambert is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Gilles Lambert has authored 138 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Surgery, 36 papers in Endocrinology, Diabetes and Metabolism and 35 papers in Molecular Biology. Recurrent topics in Gilles Lambert's work include Lipoproteins and Cardiovascular Health (74 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (29 papers) and Cancer, Lipids, and Metabolism (24 papers). Gilles Lambert is often cited by papers focused on Lipoproteins and Cardiovascular Health (74 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (29 papers) and Cancer, Lipids, and Metabolism (24 papers). Gilles Lambert collaborates with scholars based in France, United States and Réunion. Gilles Lambert's co-authors include Frank J. Gonzalez, Jerrold M. Ward, Christopher J. Sinal, Masahiro Tohkin, Masaaki Miyata, Ying‐Hue Lee, Graham P. Hayhurst, H. Bryan Brewer, Kimihiko Matsusue and Philip J. Barter and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Gilles Lambert

135 papers receiving 10.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis

2000 1.5k citations Jerrold M. Ward, Gilles Lambert et al. profile →
Hepatocyte Nuclear Factor 4α (Nuclear Receptor 2A1) Is Essential for Maintenance of Hepatic Gene Expression and Lipid Homeostasis

2001 915 citations Graham P. Hayhurst, Ying‐Hue Lee et al. Molecular and Cellular Biology profile →
The PCSK9 decade

2012 346 citations Gilles Lambert, Benjamin Choque et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gilles Lambert France	49	5.4k	3.8k	2.4k	1.9k	1.9k	138	10.4k
Liqing Yu United States	47	5.2k 1.0×	3.9k 1.0×	3.4k 1.4×	1.4k 0.7×	1.1k 0.6×	112	8.9k
Bertrand Cariou France	58	6.3k 1.2×	4.1k 1.1×	2.1k 0.9×	2.8k 1.4×	4.9k 2.6×	314	13.3k
Eran Leitersdorf Israel	41	5.2k 1.0×	2.8k 0.7×	1.2k 0.5×	867 0.4×	2.5k 1.3×	152	8.9k
Mats Rudling Sweden	46	2.5k 0.5×	2.3k 0.6×	1.4k 0.6×	2.0k 1.1×	1.9k 1.0×	97	7.9k
John F. Oram United States	62	7.2k 1.3×	5.3k 1.4×	2.8k 1.2×	929 0.5×	2.6k 1.4×	115	11.9k
Margery A. Connelly United States	48	2.4k 0.4×	3.4k 0.9×	1.1k 0.5×	1.4k 0.7×	1.8k 1.0×	225	7.7k
Nan Wang United States	52	8.0k 1.5×	5.6k 1.5×	3.7k 1.6×	1.2k 0.6×	2.0k 1.1×	91	12.4k
Uwe J.F. Tietge Netherlands	49	3.0k 0.6×	2.4k 0.6×	1.0k 0.4×	1.7k 0.9×	2.1k 1.1×	187	7.5k
Catherine Fiévet France	46	2.7k 0.5×	3.3k 0.9×	1.0k 0.4×	1.1k 0.6×	2.3k 1.2×	117	7.4k
Jun-ichi Osuga Japan	42	3.1k 0.6×	3.7k 1.0×	731 0.3×	1.6k 0.8×	1.3k 0.7×	85	7.8k

Countries citing papers authored by Gilles Lambert

Since Specialization

Citations

This map shows the geographic impact of Gilles Lambert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilles Lambert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilles Lambert more than expected).

Fields of papers citing papers by Gilles Lambert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilles Lambert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilles Lambert. The network helps show where Gilles Lambert may publish in the future.

Co-authorship network of co-authors of Gilles Lambert

This figure shows the co-authorship network connecting the top 25 collaborators of Gilles Lambert. A scholar is included among the top collaborators of Gilles Lambert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilles Lambert. Gilles Lambert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Chemello, Kévin, et al.. (2025). Apolipoprotein E Plasma Concentrations Are Predictive of Recurrent Strokes: Insights From the SPARCL Trial. Journal of the American Heart Association. 14(9). e036630–e036630.

2.

Luz, Paula M., Herak Apelian, Gilles Lambert, et al.. (2024). HIV Treatment Optimism Moderates the Relationship between Sexual Risk Behavior and HIV Risk Perception among Urban HIV-negative Gay, Bisexual, and Other Men who have Sex With Men. AIDS and Behavior. 28(8). 2683–2694.

3.

Dermody, Sarah S., Shayna Skakoon‐Sparling, Syed W. Noor, et al.. (2024). Problematic alcohol use among gay, bisexual, and other men who have sex with men in Canada: the role of proximal stressors and anxiety. Substance Abuse Treatment Prevention and Policy. 19(1). 16–16. 1 indexed citations

4.

Grewal, Ramandip, Shelley L. Deeks, Trevor Hart, et al.. (2023). HPV vaccination among gay, bisexual and other men who have sex with men in Canada's three largest cities: a person-centred approach. Journal of Men s Health. 1 indexed citations

5.

Chemello, Kévin, Antonio Gallo, Alexis F. Guédon, et al.. (2023). Lipoprotein(a): A Residual Cardiovascular Risk Factor in Statin-Treated Stroke Survivors. JACC Advances. 2(7). 100557–100557. 5 indexed citations

6.

Labbé, Annie‐Claude, Joseph Cox, Claude Fortin, et al.. (2023). Mycoplasma genitalium infection among gay, bisexual and other men who have sex with men in Montréal, Canada. Canada Communicable Disease Report. 48(11/12). 477–486. 2 indexed citations

7.

Chemello, Kévin, et al.. (2022). Recent advances in demystifying the metabolism of lipoprotein(a). Atherosclerosis. 349. 82–91. 35 indexed citations

8.

Croyal, Mikaël, Matthieu Wargny, Kévin Chemello, et al.. (2022). Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetes. Cardiovascular Diabetology. 21(1). 21–21. 16 indexed citations

9.

Ramin‐Mangata, Stéphane, Aurélie Thedrez, Brice Nativel, et al.. (2021). Effects of proprotein convertase subtilisin kexin type 9 modulation in human pancreatic beta cells function. Atherosclerosis. 326. 47–55. 20 indexed citations

10.

Brampton, Christopher, Viola Pomozi, Sara McCurdy, et al.. (2021). ABCC6 deficiency promotes dyslipidemia and atherosclerosis. Scientific Reports. 11(1). 3881–3881. 26 indexed citations

11.

Ramin‐Mangata, Stéphane, Matthieu Wargny, Matthieu Pichelin, et al.. (2019). Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes. Atherosclerosis. 293. 49–56. 17 indexed citations

12.

Croyal, Mikaël, Jean-Christophe Le Bail, Elise F. Villard, et al.. (2018). PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate. Clinical Science. 132(10). 1075–1083. 35 indexed citations

13.

David, C., Steeve Bourane, Aurélie Catan, et al.. (2017). A hemorrhagic transformation model of mechanical stroke therapy with acute hyperglycemia in mice. The Journal of Comparative Neurology. 526(6). 1006–1016. 31 indexed citations

14.

Lambert, Gilles, Francine Petrides, Mathias Chatelais, et al.. (2014). Elevated Plasma PCSK9 Level Is Equally Detrimental for Patients With Nonfamilial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia, Irrespective of Low-Density Lipoprotein Receptor Defects. Journal of the American College of Cardiology. 63(22). 2365–2373. 41 indexed citations

15.

Kwakernaak, Arjan J., Gilles Lambert, & Robin P.F. Dullaart. (2014). Plasma proprotein convertase subtilisin–kexin type 9 is predominantly related to intermediate density lipoproteins. Clinical Biochemistry. 47(7-8). 679–682. 58 indexed citations

16.

Petrides, Francine, et al.. (2013). The promises of PCSK9 inhibition. Current Opinion in Lipidology. 24(4). 307–312. 15 indexed citations

17.

Ahn, Sung‐Hoon, Yatrik M. Shah, Junko Inoue, et al.. (2008). Hepatocyte nuclear factor 4α in the intestinal epithelial cells protects against inflammatory bowel disease. Inflammatory Bowel Diseases. 14(7). 908–920. 130 indexed citations

18.

Matsusue, Kimihiko, Martin Haluzı́k, Gilles Lambert, et al.. (2003). Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. Journal of Clinical Investigation. 111(5). 737–747. 476 indexed citations

19.

Matsusue, Kimihiko, Martin Haluzı́k, Gilles Lambert, et al.. (2003). Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. Journal of Clinical Investigation. 111(5). 737–747. 478 indexed citations

20.

Hayhurst, Graham P., Ying‐Hue Lee, Gilles Lambert, Jerrold M. Ward, & Frank J. Gonzalez. (2001). Hepatocyte Nuclear Factor 4α (Nuclear Receptor 2A1) Is Essential for Maintenance of Hepatic Gene Expression and Lipid Homeostasis. Molecular and Cellular Biology. 21(4). 1393–1403. 915 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact